BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:V181 readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of V181\, from ClinicalTrials.gov estimates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07013487-11240@assetmemo.bio
DTSTAMP:20261121T004028Z
DTSTART;VALUE=DATE:20310906
DTEND;VALUE=DATE:20310907
SUMMARY:V181: Phase 3 readout est. (NCT07013487)
DESCRIPTION:V181\, phase 3\, Dengue.\nStudy: A Study to Evaluate V181 Dengu
 e Vaccine in Healthy Participants 2 to 17 Years of Age (V181-005/MOBILIZE-
 1)\nEstimated primary completion: 6 September 2031. This is a ClinicalTria
 ls.gov estimate\, not a confirmed readout date\, and it can move.\nDrug pa
 ge: https://assetmemo.bio/drug/v181#upcoming-events\nRegistry record: http
 s://clinicaltrials.gov/study/NCT07013487
URL:https://assetmemo.bio/drug/v181#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
